Shengjia Shi
Publications by Year
Research Areas
Prostate Cancer Treatment and Research, Radiopharmaceutical Chemistry and Applications, Sperm and Testicular Function, Cancer-related molecular mechanisms research, RNA Research and Splicing
Most-Cited Works
- → LncRNA-ATB promotes trastuzumab resistance and invasion-metastasis cascade in breast cancer(2015)313 cited
- → Overexpression of YAP and TAZ Is an Independent Predictor of Prognosis in Colorectal Cancer and Related to the Proliferation and Metastasis of Colon Cancer Cells(2013)266 cited
- → B7-H1 Expression Is Associated with Poor Prognosis in Colorectal Carcinoma and Regulates the Proliferation and Invasion of HCT116 Colorectal Cancer Cells(2013)187 cited
- → Interaction with CD68 and Regulation of GAS6 Expression by Endosialin in Fibroblasts Drives Recruitment and Polarization of Macrophages in Hepatocellular Carcinoma(2020)113 cited
- → Predictive value of HLA-G and HLA-E in the prognosis of colorectal cancer patients(2014)95 cited
- → Expression of Prostate-Specific Membrane Antigen in Tumor-Associated Vasculature Predicts Poor Prognosis in Hepatocellular Carcinoma(2019)67 cited
- → High mobility group box 1 promotes the epithelial-to-mesenchymal transition in prostate cancer PC3 cells via the RAGE/NF-κB signaling pathway(2018)61 cited
- → Serum miR-26a as a diagnostic and prognostic biomarker in cholangiocarcinoma(2015)58 cited
- → Therapeutic effects of human monoclonal PSMA antibody-mediated TRIM24 siRNA delivery in PSMA-positive castration-resistant prostate cancer(2019)56 cited
- → Comparison of 68Ga-PSMA-617 PET/CT with mpMRI for the detection of PCa in patients with a PSA level of 4–20 ng/ml before the initial biopsy(2020)41 cited